PPT-Impact of INSTI and TAF-related BMI changes and risk on hypertension and dyslipidemia

Dathan M Byonanebye Mark N Polizzotto Fernando Maltez Andri Rauch Katharina GrabmeierPfistershammer Ferdinand Wit Stéphane De Wit Antonella Castagna Antonella DArminio Monforte Cristina Mussini JanChristian Wasmuth Eric . Putting the Guidelines into Practice. Relationships. . with. commercial . interests. :. Grants/. Research. Support: . Speakers Bureau/. Honoraria. : . Consulting . Fees. : . Data . Safety. and Monitoring: . Shannon Harris, DNP, FNP. Objectives. Causes of hypertension. Classifications of hypertension. Risk factors. Diagnosis . Complications. Management . Final thoughts. Hypertension. The #1 modifiable risk factor for stroke. Classification (. A. dults). BP Classification. Systolic BP (mmHg). Diastolic BP (mmHg). Normal. < 120. and <. 80. Prehypertension. 120 – 139. or 80 - 89. Stage 1 hypertension. Term. Description. Angel investors. Individuals who provide early stage capital for a business start-up, usually in exchange for equity or convertible debt. B Corp. A certification provided for a fee by an NGO named B Lab. Unlike a benefit corporation, a B Corp is not a legal structure. 2013 ACC/AHA Guideline on the. Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. IMPROVE-IT. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia. Relationships. . with. commercial . interests. :. Grants/. Research. Support: . Speakers Bureau/. Honoraria. : . Consulting . Fees. : . Data . Safety. and Monitoring: . Disclosures. This program has . Sohil Rangwala. MDCM, CCFP. Quick facts. 1 in 5 Canadians have hypertension. Over 40% of Canadians aged 55-65 have hypertension. All adults with borderline BP 130-139/80-89 should get annual screening. Hypertension . doubles the risk of cardiovascular diseases, including coronary heart disease (CHD), congestive heart failure (CHF), ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. /Lipid management in . Diabetes. Dr.Zahra. . davoudi. Endocrinology department of . Loghman. Hakim Hospital, . Shahid. . Beheshti. University of Medical Sciences. A . 65 year-old woman . with medical history of . Clinics (www.dhs.state.mn.us) ProcedureRisk AssessmentThe following are examples of recommended risk factors that can be identified through the personal and family health history and physical measurem Peter Julian A. Francisco, MD, DFM. Clinical Associate Professor UPCM – Department of Family and Community Medicine. Professional Member, International Society of Hypertension. EPIDEMIOLOGY. The global prevalence of hypertension is high. In 2000 it is suggested that approximately 26 % of the total population had hypertension. (Kearney, PM et al. Lancet 2005).. Lead Speaker: Dr Tarek Antonios. Ambra Caruso, Kristina . Leonnet. and Dr Roy Jogiya. Today:. 2. Welcome and Reminders – Ambra Caruso. National Blood Pressure Programme – Kristina . Leonnet. Hypertension Webinar – Dr Tarek Antonios. Jay . Lemery. , MD, FACEP FAWM. Benjamin Easter, MD, MBA, FACEP, . AFAsMA. Kris Lehnhardt, MD, FACEP, . FAsMA. Exploration Medical Capability (ExMC). NASA Human Research Program. NASA Human Research Program. From ESH 2016 | POS 1A:. Jean-Jacques . Mourad. , MD. CHU . Avicenne. , . Bobigny. , France . Overview. Orthostatic hypertension (OH) is poorly understood. An association between mortality and OH has been demonstrated by evolving research.